The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma.
Kamand KhalajMichael A JacobsJay-Jiguang ZhuYoshua EsquenaziSigmund HsuNitin TandonAlireza AkhbardehXu ZhangRoy RiascosArash KamaliPublished in: Cancers (2024)
The study demonstrates the potential of ADC values as noninvasive imaging biomarkers for differentiating recurrent glioblastoma from radiation necrosis and bevacizumab-induced cytotoxicity.